IGM Biosciences Inc. (IGMS) Misses Q2 EPS by 3c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q2 EPS of ($1.43), $0.03 worse than the analyst estimate of ($1.40). Revenue for the quarter came in at $450 thousand versus the consensus estimate of $797 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
• BIG3 Basketball to go public via Graf Global merger at $290 million